Literature DB >> 17543662

Sepsis in the 21st century: recent definitions and therapeutic advances.

H Bryant Nguyen1, Dustin Smith.   

Abstract

Sepsis as a disease has received renewed interests since recent publications of a revised clinical definition and crucial clinical trials showing the benefits of early goal-directed resuscitation, recombinant human activated protein C, and low-dose corticosteroids. The epidemiology of sepsis has also been further examined. Management guidelines and international quality improvement efforts have been developed targeting increased disease identification, clinician education, and optimal patient care with the result of decreasing patient mortality. The evidence suggests that early recognition and early intervention are most important in affecting outcome. This article will summarize these developments in the diagnosis and management of sepsis at the turn of this century.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17543662     DOI: 10.1016/j.ajem.2006.08.015

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  22 in total

1.  P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction.

Authors:  Luiz Eduardo Baggio Savio; Mariana G Juste Andrade; Paola de Andrade Mello; Patrícia Teixeira Santana; Aline Cristina Abreu Moreira-Souza; Janaína Kolling; Aline Longoni; Linda Feldbrügge; Yan Wu; Angela T S Wyse; Simon C Robson; Robson Coutinho-Silva
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

2.  Protective effect of decursinol on mouse models of sepsis: enhancement of interleukin-10.

Authors:  Jun-Sub Jung; Ji-Jing Yan; Dong-Keun Song
Journal:  Korean J Physiol Pharmacol       Date:  2008-04-30       Impact factor: 2.016

3.  Rapid genotyping of tumor necrosis factor alpha with fluorogenic hybridization probes on the LightCycler.

Authors:  Naoko Hayashi; Yu Imamura; Yukiharu Hiyoshi; Hiroshi Takamori; Toru Beppu; Masahiko Hirota; Hideo Baba
Journal:  Clin Exp Med       Date:  2008-09-25       Impact factor: 3.984

4.  Implications of Statin Use on Vasopressor Therapy in the Setting of Septic Shock.

Authors:  Chelsey M McPheeters; Jennifer A Wiedmar; Christina M Pinkston; Kyle A Weant
Journal:  Hosp Pharm       Date:  2018-03-16

5.  Effects of anti-inflammatory vagus nerve stimulation in endotoxemic rats on blood and spleen lymphocyte subsets.

Authors:  S Mihaylova; H Schweighöfer; H Hackstein; B Rosengarten
Journal:  Inflamm Res       Date:  2014-05-07       Impact factor: 4.575

6.  Mode and mechanisms of death after orthotopic heart transplantation.

Authors:  Marmar Vaseghi; Nicolas Lellouche; Harry Ritter; Gregg C Fonarow; Jignesh K Patel; Jaime Moriguchi; Michael C Fishbein; Jon A Kobashigawa; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2009-01-16       Impact factor: 6.343

Review 7.  Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock.

Authors:  Ineke Vanlaere; Claude Libert
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

8.  Time to Administration of Antibiotics among Inpatients with Severe Sepsis or Septic Shock.

Authors:  Katie Mok; Michael D Christian; Sandra Nelson; Lisa Burry
Journal:  Can J Hosp Pharm       Date:  2014-05

9.  Eritoran: the evidence of its therapeutic potential in sepsis.

Authors:  Shahzad G Raja; Gilles D Dreyfus
Journal:  Core Evid       Date:  2008-02-29

10.  The influence of corticosteroids on the release of novel biomarkers in human endotoxemia.

Authors:  Martijn D de Kruif; Lucienne C Lemaire; Ida A Giebelen; Joachim Struck; Nils G Morgenthaler; Jana Papassotiriou; Peter J Elliott; Tom van der Poll
Journal:  Intensive Care Med       Date:  2007-12-14       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.